Verastem Gets U.S. IND Clearance for KRAS G12D Inhibitor VS-7375, Paving Way for Phase 1/2a Trial in Solid Tumors Verastem Oncology (Nasdaq: VSTM), a Boston-based biopharmaceutical company at the forefront…
CN Bio and Pharmaron Forge Long-Term Global Partnership for OOC Tech Development In a significant stride toward revolutionizing preclinical drug development, CN Bio, a leading innovator in Organ-on-a-Chip (OOC) technologies,…
Halda Therapeutics Names Dr. Eyal Attar as New Chief Medical Officer Halda Therapeutics, a clinical-stage biotechnology company pioneering a new class of cancer therapeutics, has announced the appointment of Dr.…
FDA Grants Breakthrough Status to BrainChild Bio’s CAR T Therapy for Pediatric Brain Tumors BrainChild Bio, Inc., a clinical-stage biotechnology company at the forefront of neuro-oncology cell therapy innovation, has…
EditCo Bio and Promega Team Up to Advance Cell-Based Research In a pivotal move set to reshape the landscape of functional genomics and cell engineering, EditCo Bio, Inc. has announced…
TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery In a significant advancement for data-driven drug development, TNF Pharmaceuticals has announced a strategic collaboration with Renova Health to…
Secretome Therapeutics Names Dr. Marshelle Smith Warren as New Chief Medical Officer Secretome Therapeutics, a pioneering clinical-stage biotechnology company dedicated to advancing therapies derived from neonatal cardiac progenitor cells (nCPCs),…
Biostate AI and Weill Cornell Join Forces to Harness AI for Tailored Leukemia Therapies In a groundbreaking move that combines the power of artificial intelligence (AI) with cutting-edge medical research,…
Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone In a significant advancement that underscores its continued investment in next-generation healthcare solutions, Uniphar, a global leader in pharmaceutical…
ATCC Expands Leadership Team Through Senior Executive Appointments In a move that underscores its commitment to advancing science and strengthening operational excellence, ATCC, the global leader in biological materials management…
Metro International Biotech Begins Phase 1a Trial of NAD Booster MIB-725 Metro International Biotech, LLC (MetroBiotech), a pioneering company in the development of next-generation therapies for age-associated diseases, has officially…
QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025 QIAGEN N.V. Frankfurt Prime Standard: QIA), a global leader in molecular diagnostics and sample-to-insight…